Tag: ER-/PR+

Articles

• Breast cancer types
• ER-/PR+ breast cancer
• Hormone receptor and HER2 status changes can influence prognosis
• How to optimize your breast cancer diet
• Latest research concerning breast cancer in Asian Americans
• Latest research concerning mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis
• When should mastectomy be followed by radiation treatment?

News

• 5 years of tamoxifen reduces breast cancer mortality for 15 years for ER+ disease
• Age and breast cancer subtype influence prognosis after lumpectomy
• Asian-American women have higher rates of HER2-positive breast cancer than Caucasians
• Aspirin use reduces risk of all hormone receptor types of breast cancer
• Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
• DCIS incidence has increased in recent years
• Differences in hormone receptor status between primary breast tumor and mets is common
• Different breast cancer subtypes are prone to metastasize to different sites in the body
• ER negative, PR negative, and triple negative tumors have increased risk of locoregional recurrence
• ER+/PR- or ER-/PR+ tumors more likely to recur locally than ER+/PR+ breast cancer
• Five-year prognosis by breast cancer subtype
• Hormone receptor status changes during progression in over one-third of breast cancer cases
• Knowing the receptor status of metastases improves treatment decisions
• Luminal breast cancer prognosis can vary based on other tumor characteristics
• Patients with ER-/PR+ breast cancer benefit from endocrine therapy
• Small triple negative tumors have worse prognosis than small ER+/PR+ tumors
• Survival times of stage IV breast cancer patients depends on progesterone receptor status
• Vitamin A can both promote and inhibit breast cancer growth and metastasis
• Women with high BMI may benefit less from hormonal treatments

Studies

• A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
• Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor-Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24
• Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
• Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
• Body Fat Distribution and Risk of Premenopausal Breast Cancer in the Nurses’ Health Study II
• Brain metastases free survival differs between breast cancer subtypes
• Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
• Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
• Clinically Used Breast Cancer Markers Are Heterogeneous Throughout Tumour Progression
• Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
• Discordance in hormone receptor status in breast cancer during tumor progression
• Does progesterone receptor status matter in endocrine-responsive breast cancer?
• Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
• Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
• Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
• Effect of dietary fiber intake on breast cancer risk according to estrogen and progesterone receptor status
• Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
• Evaluating Letrozole and Tamoxifen Alone and in Sequence at 8 Years Median Follow-up for Postmenopausal Women With Steroid Hormone Receptor-Positive Breast Cancer
• HDL of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells
• Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
• Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers
• Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study
• Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor
• Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark
• Outcome of special types of luminal breast cancer
• Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
• Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer
• Polyphenol-rich seaweed (Eucheuma cottonii) extract suppresses breast tumour via hormone modulation and apoptosis induction
• Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
• Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller
• Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
• Relationship of body mass index to the intrinsic subtypes of breast cancer
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
• Risk factors for postmenopausal breast cancer defined by estrogen and progesterone receptor status: The multiethnic cohort
• Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
• Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010
• The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer
• The Relationship between Alcohol Use and Risk of Breast Cancer by Histology and Hormone Receptor Status Among Women 65-79 Years of Age
• Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
• Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer